Schedule 13D ownership disclosure

AntriaBio, Inc.

Security class unavailable · CUSIP: 037230208

Event date: 2022-09-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,826,019
Percent of class
4.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000898432-23-000231
Form type
SC 13D/A
Filer
Genexine Inc.
CIK
CIK 1834377
Filed
May 03, 2023
Reporting period
Sep 15, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub